The 7th International Symposium on Autosomal Spastic Recessive Ataxia of Charlevoix-Saguenay (ARSACS) was held on 19th-20th October, welcoming 200 people online and in-person, from researchers to clinicians, neurologists, physiotherapists, medical students, patients and their families. The event was an opportunity to hear about the latest advancements in ARSACS research and build upon knowledge to lead towards treatments. Click here to read the highlights.
On 22nd and 23rd June 2023, the PROSPAX consortia held their annual meeting at the Rahmi M. Koç Museum in Istanbul, Turkey. The PROSPAX project aims to study the progression of Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS) and Spastic Paraplegia 7 (SPG7) over time; from the molecular to the clinical level, including brain imaging, markers of progression and animal models. The meeting was attended by a variety of people across the PROSPAX network, including researchers, clinicians, people with ataxia and the patient advocacy organisation Euro-ataxia. Read here some of the highlights relevant to the PROSPAX project.
Between November 1st – 4th 2022, Ataxia UK, the National Ataxia Foundation (NAF), and the Friedreich’s Ataxia Research Alliance (FARA) co-hosted the International Congress for Ataxia Research (ICAR) in Dallas, Texas, USA. The Ataxia Global Initiative (AGI) Conference was held immediately after ICAR 2022, On November 4th – 5th.
Read here some of the highlights relevant to the PROSPAX project.